We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy
This peptide corresponds to residues 411-420 of the spike protein of SARS-CoV and identified as a positive control for HLA binding studies.
Peptide Library Construction and Screening
Powerful screening tools in biological and chemical research
Sequence | One Letter Code: KLPDDFMGCV Three-Letter Code: H-Lys-Leu-Pro-Asp-Asp-Phe-Met-Gly-Cys-Val-OH |
Purity | % Peak Area By HPLC ≥ 95% |
Size | 1 mg NET peptide |
References | 1. Lv Y, et al. Identification of a novel conserved HLA-A* 0201-restricted epitope from the spike protein of SARS-CoV. BMC immunology. 2009 Dec 1;10(1):61.2. Zhou M et al. Screening and identification of severe acute respiratory syndrome-associated coronavirus-specific CTL epitopes. The Journal of Immunology. 2006 Aug 15;177(4):2138-45. |
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com